These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 9422806

  • 1. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.
    Megson IL, Greig IR, Gray GA, Webb DJ, Butler AR.
    Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806
    [Abstract] [Full Text] [Related]

  • 2. N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries.
    Megson IL, Morton S, Greig IR, Mazzei FA, Field RA, Butler AR, Caron G, Gasco A, Fruttero R, Webb DJ.
    Br J Pharmacol; 1999 Feb; 126(3):639-48. PubMed ID: 10188974
    [Abstract] [Full Text] [Related]

  • 3. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases.
    Fricker SP, Slade E, Powell NA, Vaughan OJ, Henderson GR, Murrer BA, Megson IL, Bisland SK, Flitney FW.
    Br J Pharmacol; 1997 Dec; 122(7):1441-9. PubMed ID: 9421293
    [Abstract] [Full Text] [Related]

  • 4. A novel S-nitrosothiol (RIG200) causes prolonged relaxation in dorsal hand veins with damaged endothelium.
    Sogo N, Wilkinson IB, MacCallum H, Khan SQ, Strachan FE, Newby DE, Megson IL, Webb DJ.
    Clin Pharmacol Ther; 2000 Jul; 68(1):75-81. PubMed ID: 10945318
    [Abstract] [Full Text] [Related]

  • 5. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
    Sogo N, Campanella C, Webb DJ, Megson IL.
    Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y, Karmazyn M.
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [Abstract] [Full Text] [Related]

  • 7. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
    Miller MR, Megson IL, Roseberry MJ, Mazzei FA, Butler AR, Webb DJ.
    Eur J Pharmacol; 2000 Sep 01; 403(1-2):111-9. PubMed ID: 10969151
    [Abstract] [Full Text] [Related]

  • 8. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryltrinitrate-tolerant rat femoral arteries.
    Miller MR, Roseberry MJ, Mazzei FA, Butler AR, Webb DJ, Megson IL.
    Eur J Pharmacol; 2000 Nov 24; 408(3):335-43. PubMed ID: 11090652
    [Abstract] [Full Text] [Related]

  • 9. Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery.
    White R, Hiley CR.
    Br J Pharmacol; 1998 Jul 24; 124(6):1219-26. PubMed ID: 9720794
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of nitric oxide donor and nitric oxide synthase inhibitor on the resistance, exchange and capacitance functions of the canine intestinal vasculature.
    Hsieh NK, Chang HR, Hu CT, Chen HI.
    Vascul Pharmacol; 2008 Jul 24; 48(2-3):122-8. PubMed ID: 18295548
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Endothelium-dependent and -independent vasodilator effects of eugenol in the rat mesenteric vascular bed.
    Criddle DN, Madeira SV, Soares de Moura R.
    J Pharm Pharmacol; 2003 Mar 24; 55(3):359-65. PubMed ID: 12724042
    [Abstract] [Full Text] [Related]

  • 15. Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium.
    Demontis MP, Varoni MV, Volpe AR, Emanueli C, Madeddu P.
    Br J Pharmacol; 1998 Jan 24; 123(1):129-35. PubMed ID: 9484863
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, is impaired in conscious spontaneously hypertensive rats.
    Lewis SJ, Hashmi-Hill MP, Owen JR, Sandock K, Robertson TP, Bates JN.
    Vascul Pharmacol; 2006 Jun 24; 44(6):476-90. PubMed ID: 16697269
    [Abstract] [Full Text] [Related]

  • 18. Studies of the role of endothelium-dependent nitric oxide release in the sustained vasodilator effects of corticotrophin releasing factor and sauvagine.
    Barker DM, Corder R.
    Br J Pharmacol; 1999 Jan 24; 126(1):317-25. PubMed ID: 10051151
    [Abstract] [Full Text] [Related]

  • 19. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB, Teixeira CE, Toque HA, Claudino MA, Webb RC, De Nucci G, Zanesco A, Antunes E.
    Clin Exp Pharmacol Physiol; 2006 Jan 24; 33(5-6):448-55. PubMed ID: 16700877
    [Abstract] [Full Text] [Related]

  • 20. Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol.
    Parenti A, Filippi S, Amerini S, Granger HJ, Fazzini A, Ledda F.
    J Pharmacol Exp Ther; 2000 Feb 24; 292(2):698-703. PubMed ID: 10640308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.